1. Home
  2. GNTX vs RGEN Comparison

GNTX vs RGEN Comparison

Compare GNTX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTX
  • RGEN
  • Stock Information
  • Founded
  • GNTX 1974
  • RGEN 1981
  • Country
  • GNTX United States
  • RGEN United States
  • Employees
  • GNTX N/A
  • RGEN N/A
  • Industry
  • GNTX Auto Parts:O.E.M.
  • RGEN Medical/Dental Instruments
  • Sector
  • GNTX Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • GNTX Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • GNTX 6.1B
  • RGEN 6.5B
  • IPO Year
  • GNTX N/A
  • RGEN N/A
  • Fundamental
  • Price
  • GNTX $28.51
  • RGEN $119.75
  • Analyst Decision
  • GNTX Buy
  • RGEN Buy
  • Analyst Count
  • GNTX 7
  • RGEN 10
  • Target Price
  • GNTX $29.14
  • RGEN $163.78
  • AVG Volume (30 Days)
  • GNTX 1.7M
  • RGEN 706.1K
  • Earning Date
  • GNTX 10-24-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • GNTX 1.70%
  • RGEN N/A
  • EPS Growth
  • GNTX N/A
  • RGEN N/A
  • EPS
  • GNTX 1.77
  • RGEN N/A
  • Revenue
  • GNTX $2,384,794,644.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • GNTX $11.01
  • RGEN $16.74
  • Revenue Next Year
  • GNTX $6.50
  • RGEN $13.86
  • P/E Ratio
  • GNTX $15.94
  • RGEN N/A
  • Revenue Growth
  • GNTX 2.43
  • RGEN 8.73
  • 52 Week Low
  • GNTX $20.28
  • RGEN $102.97
  • 52 Week High
  • GNTX $31.72
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • GNTX 61.35
  • RGEN 50.04
  • Support Level
  • GNTX $27.53
  • RGEN $112.73
  • Resistance Level
  • GNTX $28.64
  • RGEN $122.71
  • Average True Range (ATR)
  • GNTX 0.50
  • RGEN 4.63
  • MACD
  • GNTX -0.10
  • RGEN -0.46
  • Stochastic Oscillator
  • GNTX 78.95
  • RGEN 55.87

About GNTX Gentex Corporation

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: